Intelligence · Drug directory
Pipeline & Investigational Drugs
Investigational and clinical-stage compounds without US or EU marketing approval — linked to ClinicalTrials.gov programs and congress coverage.
Quick answer
Pipeline & investigational drugs: NovaPharmaNews tracks 1,610 pharmaceutical drugs in this segment. Investigational and clinical-stage compounds without US or EU marketing approval — linked to ClinicalTrials.gov programs and congress coverage.
-
protein hydrolysate formula with medium chain triglycerides
APTAMIL GOLD+ PEPTI-JUNIOR
-
quizartinib hydrochloride
VANFLYTA
-
ramosetron hydrochloride
IRRIBOW
-
recombinant adsorbed bivalent human papillomavirus-like particle vaccine (derived from trichoplusia ni cell)
CERVARIX
-
recombinant coronavirus (sars-cov-2) vaccine
COVGOZE
-
regorafenib hydrate
STIVARGA INITIAL APPROVAL
-
resorcinol
NULL
-
respiratory syncytial virus rna vaccine
MRESVIA
-
ritlecitinib tosilate
LITFULO
-
salicylic acid
NULL
-
salicylic acid (extemporaneous formula)
NULL
-
salicylic acid and sulfur aqueous
NULL
-
salicylic acid ointment
NULL
-
sepetaprost
SETANEO
-
simple ointment (white) (for use only as a base combined with active ingredients)
NULL
-
simple ointment (yellow) (for use only as a base combined with active ingredients)
NULL
-
siponimod fumaric acid
MAYZENT
-
sitagliptin phosphate hydrate
JANUVIA/GLACTIV
-
sodium chloride + hypochlorous acid + sodium hypochlorite
MICRODACYN
-
sodium chloride solution
NULL
-
sodium citrate
NULL
-
sodium thiosulfate (use as additive only)
NULL
-
solutions
NULL
-
soy lecithin + tocopherol + vitamin a
TEARSAGAIN
Frequently asked questions
How many pipeline drugs are listed?
1,610 drug profiles match this regulatory segment in our published index.
Where does approval data come from?
Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.